Suppl. Fig. 2 from Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment Article Swipe
Luo Ren
,
Elke Firat
,
Simone Gaedicke
,
Elena Guffart
,
Tsubasa Watanabe
,
Gabriele Niedermann
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22471544.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22471544.v1
Tumor growth delay analysis for the data presented in Fig. 1.
Related Topics
Concepts
Blockade
CXCR3
Abscopal effect
Cancer research
Cisplatin
Immune checkpoint
Chemistry
Medicine
Internal medicine
Immunotherapy
Immunology
Immune system
Chemokine
Chemotherapy
Receptor
Chemokine receptor
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.22471544.v1
- https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_2_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471544/1/files/39923027.pdf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4361935062
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4361935062Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.22471544.v1Digital Object Identifier
- Title
-
Suppl. Fig. 2 from Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell RecruitmentWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-31Full publication date if available
- Authors
-
Luo Ren, Elke Firat, Simone Gaedicke, Elena Guffart, Tsubasa Watanabe, Gabriele NiedermannList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.22471544.v1Publisher landing page
- PDF URL
-
https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_2_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471544/1/files/39923027.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_2_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471544/1/files/39923027.pdfDirect OA link when available
- Concepts
-
Blockade, CXCR3, Abscopal effect, Cancer research, Cisplatin, Immune checkpoint, Chemistry, Medicine, Internal medicine, Immunotherapy, Immunology, Immune system, Chemokine, Chemotherapy, Receptor, Chemokine receptorTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4361935062 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.22471544.v1 |
| ids.doi | https://doi.org/10.1158/1078-0432.22471544.v1 |
| ids.openalex | https://openalex.org/W4361935062 |
| fwci | |
| type | preprint |
| title | Suppl. Fig. 2 from Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T12064 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9815999865531921 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2746 |
| topics[0].subfield.display_name | Surgery |
| topics[0].display_name | Intraperitoneal and Appendiceal Malignancies |
| topics[1].id | https://openalex.org/T10073 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9577999711036682 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2721 |
| topics[1].subfield.display_name | Hepatology |
| topics[1].display_name | Hepatocellular Carcinoma Treatment and Prognosis |
| topics[2].id | https://openalex.org/T10158 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9503999948501587 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cancer Immunotherapy and Biomarkers |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778468042 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7957851886749268 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q273976 |
| concepts[0].display_name | Blockade |
| concepts[1].id | https://openalex.org/C25532541 |
| concepts[1].level | 5 |
| concepts[1].score | 0.6548460125923157 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q655541 |
| concepts[1].display_name | CXCR3 |
| concepts[2].id | https://openalex.org/C2781274730 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6028642058372498 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q4669679 |
| concepts[2].display_name | Abscopal effect |
| concepts[3].id | https://openalex.org/C502942594 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5694671273231506 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[3].display_name | Cancer research |
| concepts[4].id | https://openalex.org/C2778239845 |
| concepts[4].level | 3 |
| concepts[4].score | 0.561224639415741 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q412415 |
| concepts[4].display_name | Cisplatin |
| concepts[5].id | https://openalex.org/C2780851360 |
| concepts[5].level | 4 |
| concepts[5].score | 0.5041364431381226 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q21686041 |
| concepts[5].display_name | Immune checkpoint |
| concepts[6].id | https://openalex.org/C185592680 |
| concepts[6].level | 0 |
| concepts[6].score | 0.45903635025024414 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[6].display_name | Chemistry |
| concepts[7].id | https://openalex.org/C71924100 |
| concepts[7].level | 0 |
| concepts[7].score | 0.3497779965400696 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[7].display_name | Medicine |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.251932293176651 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C2777701055 |
| concepts[9].level | 3 |
| concepts[9].score | 0.23272082209587097 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[9].display_name | Immunotherapy |
| concepts[10].id | https://openalex.org/C203014093 |
| concepts[10].level | 1 |
| concepts[10].score | 0.16993120312690735 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[10].display_name | Immunology |
| concepts[11].id | https://openalex.org/C8891405 |
| concepts[11].level | 2 |
| concepts[11].score | 0.16678932309150696 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[11].display_name | Immune system |
| concepts[12].id | https://openalex.org/C13373296 |
| concepts[12].level | 3 |
| concepts[12].score | 0.1022801399230957 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q421866 |
| concepts[12].display_name | Chemokine |
| concepts[13].id | https://openalex.org/C2776694085 |
| concepts[13].level | 2 |
| concepts[13].score | 0.07245376706123352 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[13].display_name | Chemotherapy |
| concepts[14].id | https://openalex.org/C170493617 |
| concepts[14].level | 2 |
| concepts[14].score | 0.06713151931762695 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[14].display_name | Receptor |
| concepts[15].id | https://openalex.org/C12823836 |
| concepts[15].level | 4 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q24720618 |
| concepts[15].display_name | Chemokine receptor |
| keywords[0].id | https://openalex.org/keywords/blockade |
| keywords[0].score | 0.7957851886749268 |
| keywords[0].display_name | Blockade |
| keywords[1].id | https://openalex.org/keywords/cxcr3 |
| keywords[1].score | 0.6548460125923157 |
| keywords[1].display_name | CXCR3 |
| keywords[2].id | https://openalex.org/keywords/abscopal-effect |
| keywords[2].score | 0.6028642058372498 |
| keywords[2].display_name | Abscopal effect |
| keywords[3].id | https://openalex.org/keywords/cancer-research |
| keywords[3].score | 0.5694671273231506 |
| keywords[3].display_name | Cancer research |
| keywords[4].id | https://openalex.org/keywords/cisplatin |
| keywords[4].score | 0.561224639415741 |
| keywords[4].display_name | Cisplatin |
| keywords[5].id | https://openalex.org/keywords/immune-checkpoint |
| keywords[5].score | 0.5041364431381226 |
| keywords[5].display_name | Immune checkpoint |
| keywords[6].id | https://openalex.org/keywords/chemistry |
| keywords[6].score | 0.45903635025024414 |
| keywords[6].display_name | Chemistry |
| keywords[7].id | https://openalex.org/keywords/medicine |
| keywords[7].score | 0.3497779965400696 |
| keywords[7].display_name | Medicine |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.251932293176651 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/immunotherapy |
| keywords[9].score | 0.23272082209587097 |
| keywords[9].display_name | Immunotherapy |
| keywords[10].id | https://openalex.org/keywords/immunology |
| keywords[10].score | 0.16993120312690735 |
| keywords[10].display_name | Immunology |
| keywords[11].id | https://openalex.org/keywords/immune-system |
| keywords[11].score | 0.16678932309150696 |
| keywords[11].display_name | Immune system |
| keywords[12].id | https://openalex.org/keywords/chemokine |
| keywords[12].score | 0.1022801399230957 |
| keywords[12].display_name | Chemokine |
| keywords[13].id | https://openalex.org/keywords/chemotherapy |
| keywords[13].score | 0.07245376706123352 |
| keywords[13].display_name | Chemotherapy |
| keywords[14].id | https://openalex.org/keywords/receptor |
| keywords[14].score | 0.06713151931762695 |
| keywords[14].display_name | Receptor |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.22471544.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_2_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471544/1/files/39923027.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.22471544.v1 |
| locations[1].id | pmh:oai:figshare.com:article/22471544 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Suppl_Fig_2_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471544 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5027929564 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9508-5497 |
| authorships[0].author.display_name | Luo Ren |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ren Luo |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5086398080 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5959-4523 |
| authorships[1].author.display_name | Elke Firat |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Elke Firat |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5077293409 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7496-4994 |
| authorships[2].author.display_name | Simone Gaedicke |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Simone Gaedicke |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5084350302 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-7691-8411 |
| authorships[3].author.display_name | Elena Guffart |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Elena Guffart |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5102268946 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Tsubasa Watanabe |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Tsubasa Watanabe |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5081477925 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1710-0975 |
| authorships[5].author.display_name | Gabriele Niedermann |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Gabriele Niedermann |
| authorships[5].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_2_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471544/1/files/39923027.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Suppl. Fig. 2 from Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12064 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9815999865531921 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2746 |
| primary_topic.subfield.display_name | Surgery |
| primary_topic.display_name | Intraperitoneal and Appendiceal Malignancies |
| related_works | https://openalex.org/W2086954818, https://openalex.org/W2055468987, https://openalex.org/W2263980547, https://openalex.org/W1795191204, https://openalex.org/W4361271945, https://openalex.org/W2085972006, https://openalex.org/W3197188017, https://openalex.org/W4200507838, https://openalex.org/W4362158722, https://openalex.org/W3166800855 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1078-0432.22471544.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_2_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471544/1/files/39923027.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.22471544.v1 |
| primary_location.id | doi:10.1158/1078-0432.22471544.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_2_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471544/1/files/39923027.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.22471544.v1 |
| publication_date | 2023-03-31 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.in | 8 |
| abstract_inverted_index.for | 4 |
| abstract_inverted_index.the | 5 |
| abstract_inverted_index.Fig. | 9 |
| abstract_inverted_index.data | 6 |
| abstract_inverted_index.delay | 2 |
| abstract_inverted_index.growth | 1 |
| abstract_inverted_index.analysis | 3 |
| abstract_inverted_index.presented | 7 |
| abstract_inverted_index.1.</p> | 10 |
| abstract_inverted_index.<p>Tumor | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 6 |
| citation_normalized_percentile.value | 0.08520093 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |